Pregabalin Capsule
Product Images NDC 60760-682

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 60760-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

682-30 (Pregabalin 60760 682 30)

This is a product label for Pregabalin capsules (150mg) manufactured by Alkem Laboratories Ltd. The label includes important information such as NDC numbers, lot numbers, expiration dates, and storage instructions (Store at controlled room temperature 15°-30°C). It is important to use the medication as directed.*

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Pregabalin-fig-a (Pregabalin Fig A)

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This is a summary of multiple studies evaluating different doses of a medication compared to a placebo. The studies include varying doses of the medication administered daily. The results show percentages for each study group, indicating statistical significance compared to the placebo group.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

This text appears to contain information about a study involving patients taking different doses of Pregabalin and a placebo. The text also mentions the improvement of pain compared to baseline.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This text provides data on the percentage of patients improved based on different doses of the drug Pregabalin. It shows the improvement in pain from baseline for various doses including 100mg, 450mg, 300mg, and a placebo group. The information appears to be part of a study or report analyzing the effectiveness of Pregabalin in managing pain.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.